United States regulation laying out the fees payable by sponsors when making applications to FDA for clinical trial or marketing authorisations of generic drug products.
Menu
United States regulation laying out the fees payable by sponsors when making applications to FDA for clinical trial or marketing authorisations of generic drug products.
Use our tool to look up the definition of terms in our glossary.
©2023 Trilogy Writing & Consulting GmbH | Impressum (Legal Information & Cookie Policy)